非甾体抗炎药使用对偏头痛相关心肌梗死与缺血性卒中风险的影响:一项基于人群的队列研究
丹麦全国性队列研究纳入1995至2021年医院诊断偏头痛者46,647例及匹配对照186,588例、初级保健诊断偏头痛者288,529例及匹配对照1,154,116例,比较有无NSAID使用期间的心血管风险。医院诊断偏头痛者20年心肌梗死和缺血卒中风险升高,且该升高不能由NSAID相关心血管风险解释。
要点
- 医院诊断偏头痛者20年心肌梗死风险3.3% vs 对照2.2%,aHR 1.53(95%CI 1.40-1.67)。
- 医院诊断偏头痛者20年缺血卒中风险4.5% vs 对照2.4%,aHR 1.94(95%CI 1.80-2.10)。
- 初级保健诊断偏头痛者无论是否使用NSAID,结局风险总体未高于对照。
核心结论
- 医院诊断偏头痛相关的心肌梗死和缺血性卒中风险升高不能由NSAID相关心血管风险解释。
研究设计与样本
- 丹麦全国性基于人群的队列研究,纳入1995至2021年首次医院诊断偏头痛或至少2次偏头痛药物处方配药(初级保健诊断)者。
- 纳入按出生年份和性别匹配的一般人群对照;排除既往偏头痛诊断、至少2次偏头痛药物处方配药、心肌梗死或缺血性卒中者。
- 采用Aalen-Johansen估计量计算绝对风险,Cox回归估计调整风险比(aHR)。
主要发现
- 医院诊断偏头痛组46,647例 vs 匹配对照186,588例,20年心肌梗死风险3.3% vs 2.2%(aHR 1.53;95%CI 1.40-1.67)。
- 医院诊断偏头痛组 vs 匹配对照,20年缺血性卒中风险4.5% vs 2.4%(aHR 1.94;95%CI 1.80-2.10)。
- 心肌梗死风险升高在有无NSAID使用期间相当;缺血性卒中在有无NSAID使用期间点估计均升高,无NSAID使用期间aHR 1.97(95%CI 1.82-2.13)似高于有NSAID使用期间aHR 1.49(95%CI 1.13-1.97)。
- 初级保健诊断偏头痛组288,529例 vs 匹配对照1,154,116例,无论是否使用NSAID,结局风险总体未高于对照。
关键数值与推荐
- 证据等级:Class III,NSAID相关心血管风险不能解释偏头痛与心肌梗死或缺血性卒中的关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Migraine is linked to higher risks of myocardial infarction and ischemic stroke, but it is uncertain whether this risk is due to nonsteroidal anti-inflammatory drug (NSAID) use. This study aimed to examine the cardiovascular risks associated with migraine during time with and without NSAID use. METHODS: We conducted a Danish nationwide population-based cohort study of individuals with a first-time hospital diagnosis of migraine (hospital-diagnosed) or at least 2 prescription fillings for migraine medication (primary care-diagnosed) between 1995 and 2021. We included comparison cohorts matched by birth year and sex from the general population. Exclusion criteria included previous migraine diagnosis, at least 2 prescription fillings for migraine medication, myocardial infarction, or ischemic stroke. We used the Aalen-Johansen estimator to calculate absolute risks and Cox regression to estimate adjusted hazard ratios (aHRs) for the association between migraine and the outcomes. RESULTS: The study included 46,647 individuals with hospital-diagnosed migraine and 186,588 matched comparisons and 288,529 individuals with primary care-diagnosed migraine and 1,154,116 matched comparisons. Those with hospital-diagnosed migraine had higher 20-year risks of myocardial infarction (3.3% vs 2.2%; aHR 1.53; 95% CI 1.40-1.67) and ischemic stroke (4.5% vs 2.4%; aHR 1.94; 95% CI 1.80-2.10) than comparisons. These increased risks were comparable during time with and without NSAID use for myocardial infarction. For ischemic stroke, the point estimate remained increased during time with and without NSAID use, although it seemed higher during time without NSAID use (aHR 1.97; 95% CI 1.82-2.13) than with NSAID use (aHR 1.49; 95% CI 1.13-1.97). Individuals with primary care-diagnosed migraine overall did not have higher risks of the outcomes than comparisons, regardless of NSAID use. DISCUSSION: The increased risk of myocardial infarction and ischemic stroke associated with hospital-diagnosed migraine could not be explained by NSAID-associated cardiovascular risks. CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that NSAID-associated cardiovascular risks cannot explain the association between migraine and myocardial infarction or ischemic stroke.
引用
- Bonnesen K, Fuglsang CH, Schmidt M, et al. Impact of Nonsteroidal Anti-Inflammatory Drug Use on the Migraine-Associated Risk of Myocardial Infarction and Ischemic Stroke: A Population-Based Cohort Study. Neurology. 2024. PMID: 39621948. doi:10.1212/WNL.0000000000210034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。